Published in Thorax on October 01, 2002
Altered expression of T cell immunoglobulin-mucin (TIM) molecules in bronchoalveolar lavage CD4+ T cells in sarcoidosis. Respir Res (2009) 0.81
Comparative analysis of mycobacterial heat shock proteins-induced apoptosis of peripheral blood mononuclear cells in sarcoidosis and tuberculosis. J Clin Immunol (2006) 0.79
Genetic characterization and fine mapping of susceptibility loci for sarcoidosis in African Americans on chromosome 5. Hum Genet (2006) 0.78
Caspases: enemies within. Science (1998) 19.45
Sarcoidosis. N Engl J Med (1997) 11.02
Pulmonary sarcoidosis: a disorder mediated by excess helper T-lymphocyte activity at sites of disease activity. N Engl J Med (1981) 4.02
Caspase activation is required for T cell proliferation. J Exp Med (1999) 2.74
IL-15: a pleiotropic cytokine with diverse receptor/signaling pathways whose expression is controlled at multiple levels. Immunity (1996) 2.23
Interleukin-15 protects from lethal apoptosis in vivo. Nat Med (1997) 2.22
Early activation of caspases during T lymphocyte stimulation results in selective substrate cleavage in nonapoptotic cells. J Exp Med (1999) 2.12
Regulation of T-cell apoptosis in inflammatory bowel disease: to die or not to die, that is the mucosal question. Trends Immunol (2001) 1.52
Sarcoidosis: immunopathogenetic concepts and their clinical application. Eur Respir J (1998) 1.49
Caspases: more than just killers? Trends Immunol (2001) 1.39
Cell death in granulomata: the role of apoptosis. J Clin Pathol (1987) 1.35
IL-15, an immunomodulator of T cell responses in intracellular infection. J Immunol (1997) 1.34
Relationship between changed alveolar-capillary permeability and angiotensin converting enzyme activity in serum in sarcoidosis. Thorax (1986) 1.28
Role of IL-15, IL-2, and their receptors in the development of T cell alveolitis in pulmonary sarcoidosis. J Immunol (1996) 1.21
Cytochrome c release and caspase activation in hydrogen peroxide- and tributyltin-induced apoptosis. FEBS Lett (1998) 1.18
New pathogenetic insights into the sarcoid granuloma. Curr Opin Rheumatol (2000) 1.16
Sarcoidosis: TNF-alpha release from alveolar macrophages and serum level of sIL-2R are prognostic markers. Am J Respir Crit Care Med (1997) 1.13
Highly activated T-cell receptor AV2S3(+) CD4(+) lung T-cell expansions in pulmonary sarcoidosis. Am J Respir Crit Care Med (2001) 1.12
Expression of tumor necrosis factor-receptor superfamily members by lung T lymphocytes in interstitial lung disease. Am J Respir Crit Care Med (1996) 1.03
Phenotypic analysis of lymphocytes and monocytes/macrophages in peripheral blood and bronchoalveolar lavage fluid from patients with pulmonary sarcoidosis. Thorax (1999) 1.02
Activation of caspase-3-like enzymes in non-apoptotic T cells. Eur J Immunol (1998) 0.98
Caspase involvement in the induction of apoptosis by the environmental toxicants tributyltin and triphenyltin. Toxicol Appl Pharmacol (1999) 0.96
Apoptosis in the course of granulomatous inflammation in pulmonary sarcoidosis. Eur Respir J (1999) 0.95
The role of calcium in pre- and postmitochondrial events in tributyltin-induced T-cell apoptosis. Biochem Biophys Res Commun (1999) 0.93
Lymphocyte dynamics: caution in interpreting BAL numbers. Thorax (1997) 0.89
Organotin-induced caspase activation and apoptosis in human peripheral blood lymphocytes. Chem Res Toxicol (2001) 0.85
Tributyltin-induced apoptosis requires glycolytic adenosine trisphosphate production. Chem Res Toxicol (1999) 0.82
Cell apoptosis and granulomatous lung diseases. Curr Opin Pulm Med (1998) 0.81
Expression of bcl-2 and Epstein-Barr virus LMP1 in lymphocytic interstitial pneumonia. Thorax (1997) 0.81
Increased expression of apoptosis signalling receptors by alveolar macrophages in sarcoidosis. Eur Respir J (1999) 0.81
ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders. Sarcoidosis Vasc Diffuse Lung Dis (1999) 3.69
Smoking increases peptidylarginine deiminase 2 enzyme expression in human lungs and increases citrullination in BAL cells. Ann Rheum Dis (2008) 2.27
Two fatalities from ingestion of acetonitrile: limited specificity of analysis by headspace gas chromatography. J Anal Toxicol (1992) 2.09
Exosomes with major histocompatibility complex class II and co-stimulatory molecules are present in human BAL fluid. Eur Respir J (2003) 1.97
Increased risk for cancer following sarcoidosis. Am J Respir Crit Care Med (1999) 1.76
T cell receptor V-segment frequencies in peripheral blood T cells correlate with human leukocyte antigen type. J Exp Med (1991) 1.69
Characterisation of natural killer cells and CD56+ T-cells in sarcoidosis patients. Eur Respir J (2005) 1.62
Distribution of toxaphene, DDT, and PCB among lipoprotein fractions in rat and human plasma. Arch Toxicol (1990) 1.57
Lung and blood T-cell receptor repertoire in extrinsic allergic alveolitis. Eur Respir J (1997) 1.54
Risk of tuberculosis in a large sample of patients with coeliac disease--a nationwide cohort study. Aliment Pharmacol Ther (2011) 1.54
Changes in immune regulation in response to examination stress in atopic and healthy individuals. Clin Exp Allergy (2006) 1.52
Regulated expression of integrins and other adhesion molecules during differentiation of monocytes into macrophages. Cell Immunol (1994) 1.51
Hydrophobic surfactant-associated polypeptides: SP-C is a lipopeptide with two palmitoylated cysteine residues, whereas SP-B lacks covalently linked fatty acyl groups. Proc Natl Acad Sci U S A (1990) 1.45
Pulmonary reactions caused by welding-induced decomposed trichloroethylene. Chest (1991) 1.44
Coeliac disease and risk of tuberculosis: a population based cohort study. Thorax (2006) 1.41
[GHB--dangerous, addictive and uncontrollable "party drug"]. Lakartidningen (2001) 1.40
Measurement of CSF dynamics with oscillating pressure infusion. Acta Neurol Scand (2012) 1.40
Role of innate and adaptive immunity in the outcome of primary infection with Chlamydia pneumoniae, as analyzed in genetically modified mice. J Immunol (1999) 1.39
Antibacterial components in bronchoalveolar lavage fluid from healthy individuals and sarcoidosis patients. Am J Respir Crit Care Med (1999) 1.37
Restricted V alpha 2.3 gene usage by CD4+ T lymphocytes in bronchoalveolar lavage fluid from sarcoidosis patients correlates with HLA-DR3. Eur J Immunol (1992) 1.35
Randomized clinical trial of Lichtenstein patch or Prolene Hernia System for inguinal hernia repair. Br J Surg (2006) 1.34
Spin torque-generated magnetic droplet solitons. Science (2013) 1.33
IFN-alpha beta-dependent, IFN-gamma secretion by bone marrow-derived macrophages controls an intracellular bacterial infection. J Immunol (2001) 1.32
Hyaluronate in bronchoalveolar lavage fluid: a new marker in sarcoidosis reflecting pulmonary disease. Br Med J (Clin Res Ed) (1985) 1.31
Regulation and role of IFN-gamma in the innate resistance to infection with Chlamydia pneumoniae. J Immunol (2000) 1.29
Relationship between changed alveolar-capillary permeability and angiotensin converting enzyme activity in serum in sarcoidosis. Thorax (1986) 1.28
HLA-DR predicts the prognosis in Scandinavian patients with pulmonary sarcoidosis. Am J Respir Crit Care Med (1997) 1.27
Analysis of intracellular cytokines in CD4+ and CD8+ lung and blood T cells in sarcoidosis. Am J Respir Crit Care Med (2001) 1.19
Road tunnel air pollution induces bronchoalveolar inflammation in healthy subjects. Eur Respir J (2007) 1.13
Highly activated T-cell receptor AV2S3(+) CD4(+) lung T-cell expansions in pulmonary sarcoidosis. Am J Respir Crit Care Med (2001) 1.12
T-cell receptor variable region gene usage by CD4+ and CD8+ T cells in bronchoalveolar lavage fluid and peripheral blood of sarcoidosis patients. Proc Natl Acad Sci U S A (1994) 1.11
Analysis of regulatory T cell associated forkhead box P3 expression in the lungs of patients with sarcoidosis. Clin Exp Immunol (2008) 1.10
Increased interleukin-13 mRNA expression in bronchoalveolar lavage cells of atopic patients with mild asthma after repeated low-dose allergen provocations. Respir Med (2000) 1.10
Dissolution of metals by human and rabbit alveolar macrophages. Br J Ind Med (1985) 1.10
Bronchoalveolar lavage fluid exosomes contribute to cytokine and leukotriene production in allergic asthma. Allergy (2012) 1.08
Present progress towards the laboratory colonization of African Simuliidae (Diptera). Tropenmed Parasitol (1975) 1.07
Inflammatory cell response in bronchoalveolar lavage fluid after nitrogen dioxide exposure of healthy subjects: a dose-response study. Eur Respir J (1991) 1.05
CSF pressure assessed by lumbar puncture agrees with intracranial pressure. Neurology (2007) 1.04
Tuberculostearic acid in lymph nodes from patients with sarcoidosis. Sarcoidosis (1987) 1.04
No penetration of orally administered N-acetylcysteine into bronchoalveolar lavage fluid. Eur J Respir Dis (1987) 1.03
Phenotypic analysis of lymphocytes and monocytes/macrophages in peripheral blood and bronchoalveolar lavage fluid from patients with pulmonary sarcoidosis. Thorax (1999) 1.02
Lung restricted T cell receptor AV2S3+ CD4+ T cell expansions in sarcoidosis patients with a shared HLA-DRbeta chain conformation. Thorax (2002) 1.02
Bronchoalveolar lavage in COPD: fluid recovery correlates with the degree of emphysema. Eur Respir J (2005) 1.01
Allergen provocation increases TH2-cytokines and FOXP3 expression in the asthmatic lung. Allergy (2009) 0.99
Evidence for mast cell activation during exercise-induced bronchoconstriction. Eur Respir J (1998) 0.98
T cell receptor (TCR) V gene usage in patients with systemic necrotizing vasculitis. Clin Exp Immunol (1995) 0.98
Is the PiF allele of alpha 1-antitrypsin associated with pulmonary disease? Clin Genet (1984) 0.97
Phenotypic analysis of alveolar macrophages and lymphocytes following allergen inhalation by atopic subjects with mild asthma. Respir Med (2005) 0.96
HLA-DRB1* alleles and symptoms associated with Heerfordt's syndrome in sarcoidosis. Eur Respir J (2011) 0.96
Alterations in bronchoalveolar lavage fluid but not in lung function and bronchial responsiveness in swine confinement workers. Chest (1992) 0.96
Extracellular matrix components in bronchoalveolar lavage fluid in sarcoidosis and their relationship to signs of alveolitis. Am Rev Respir Dis (1990) 0.95
Expression of Th1 markers by lung accumulated T cells in pulmonary sarcoidosis. J Intern Med (2003) 0.95
Analysis of gamma delta V region usage in normal and diseased human intestinal biopsies and peripheral blood by polymerase chain reaction (PCR) and flow cytometry. Clin Exp Immunol (1995) 0.94
Reduced Th1 response in the lungs of HLA-DRB1*0301 patients with pulmonary sarcoidosis. Eur Respir J (2006) 0.94
Measuring pulsatile flow in cerebral arteries using 4D phase-contrast MR imaging. AJNR Am J Neuroradiol (2013) 0.94
The role of calcium in pre- and postmitochondrial events in tributyltin-induced T-cell apoptosis. Biochem Biophys Res Commun (1999) 0.93
Lung T-helper cells expressing T-cell receptor AV2S3 associate with clinical features of pulmonary sarcoidosis. Am J Respir Crit Care Med (2000) 0.93
Lung function and bronchial reactivity in aluminum potroom workers. Scand J Work Environ Health (1989) 0.93
Effects of oral N-acetylcysteine on cell content and macrophage function in bronchoalveolar lavage from healthy smokers. Eur Respir J (1988) 0.93
The conventionally ventilated operating theatre and air contamination control during cardiac surgery--bacteriological and particulate matter control garment options for low level contamination. Eur J Cardiothorac Surg (1998) 0.93
Characterization of the T-cell receptor V-beta repertoire in Kawasaki disease. Scand J Immunol (1998) 0.92
Human herpesvirus-6 (HHV-6, HBLV) in sarcoidosis and lymphoproliferative disorders. J Virol Methods (1988) 0.92
HIV infection leads to differential expression of T-cell receptor V beta genes in CD4+ and CD8+ T cells. AIDS (1993) 0.92
Quartz selectively down-regulates CR1 on activated human granulocytes. J Leukoc Biol (1993) 0.91
Expanded T cell populations in patients with Wegener's granulomatosis: characteristics and correlates with disease activity. J Clin Immunol (1998) 0.91
Decreased pulmonary levels of the anti-inflammatory Clara cell 16 kDa protein after induction of airway inflammation in asthmatics. Cell Mol Life Sci (2000) 0.90
Spin-wave-mode coexistence on the nanoscale: a consequence of the Oersted-field-induced asymmetric energy landscape. Phys Rev Lett (2013) 0.90
Functional, morphological, and phenotypical differences between rat alveolar and interstitial macrophages. Am J Respir Cell Mol Biol (1997) 0.90
Predominant T cell receptor V gene usage in patients with abnormal clones of B cells. Blood (1991) 0.90
Cerebrospinal fluid hydrodynamics after placement of a shunt with an antisiphon device: a long-term study. J Neurosurg (2001) 0.90
Markers of activity in clinically recovered human leukocyte antigen-DR17-positive sarcoidosis patients. Eur Respir J (2003) 0.90
CD4+ and CD8+ T cell expansions using selected TCR V and J gene segments at the onset of giant cell arteritis. Arthritis Rheum (1994) 0.90
Selective CD8+ T cells accumulate in the lungs of patients with allergic asthma after allergen bronchoprovocation. Clin Exp Immunol (1998) 0.89
Restricted T cell receptor V-beta and J-beta usage in T cells from interleukin-2-cultured lymphocytes of ovarian and renal carcinomas. Cancer Immunol Immunother (1993) 0.89